Japan Alteplase Clinical Trial(J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator for Ischemic Stroke

This study has been completed.

Study NCT00147316 Information provided by Mitsubishi Tanabe Pharma Corporation

First Received: September 5, 2005 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2003
Estimated Primary Completion Date:	No date given